trending Market Intelligence /marketintelligence/en/news-insights/trending/iw1cq5vdzjt-kcrgq4xa_q2 content esgSubNav
In This List

Bone Therapeutics appoints board chairman

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bone Therapeutics appoints board chairman

Bone Therapeutics SA appointed Jean Stéphenne as the chairman of the company's board, effective Feb. 20.

Stéphenne replaces Steve Swinson, who informed the board of his intention to step down.

Previously, Stéphenne has served as a member of the corporate executive team at GlaxoSmithKline PLC and CEO of GSK Vaccines, formerly known as GSK Biologicals.